1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative yoy deferred tax while CRON.TO stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
47.30%
Lower 'other working capital' growth vs. CRON.TO's 125.87%. David Dodd would see fewer unexpected short-term demands on cash.
77.70%
Lower 'other non-cash' growth vs. CRON.TO's 20671.90%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
85.85%
Operating cash flow growth below 50% of CRON.TO's 234.45%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
98.89%
Less 'other investing' outflow yoy vs. CRON.TO's 3012.24%. David Dodd would see a stronger short-term cash position unless competitor invests more wisely.
98.89%
Investing outflow well above CRON.TO's 98.22%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
-48.35%
We cut debt repayment yoy while CRON.TO is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
-37.35%
Negative yoy issuance while CRON.TO is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.